Clinical Study to Evaluate Food-Effect on Pharmacokinetics and Pharmacodynamics of Single Oral Dose of CJ-12420 in Healthy Male Subjects
Latest Information Update: 20 Jul 2021
At a glance
- Drugs Tegoprazan (Primary)
- Indications Erosive oesophagitis; Gastric cancer; Gastro-oesophageal reflux; Helicobacter infections; Peptic ulcer
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors CJ Cheiljedang Corp.; HK inno.N
- 07 Jul 2021 Results published in the Clinical Therapeutics
- 22 Apr 2013 New trial record